๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Insulin glargine - Medicines in Ireland

14 authorised products containing Insulin glargine, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 14 authorised medicines
MedicineActive substanceLicence holderStatus
ABASAGLAR 100 units/mL solution for injection in a cartridge
EU/1/14/944/001-004
Insulin glargine Eli Lilly Nederland B.V. โ€”
ABASAGLAR 100 units/mL solution for injection in a pre-filled pen
EU/1/14/944/005-008
Insulin glargine Eli Lilly Nederland B.V. โ€”
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/005
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/006
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/007
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/001
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/002
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/003
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/004
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen
EU/1/00/134/030-037
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Semglee 100 units/ml solution for injection in pre-filled pen
EU/1/18/1270/001-004
Insulin glargine Biosimilar Collaborations Ireland Limited โ€”
Suliqua 100 units/ml + 33 micrograms/ml solution for injection in pre-filled pen
EU/1/16/1157/003-004
Lixisenatide, Insulin glargine Sanofi-Aventis Groupe โ€”
Suliqua 100 units/ml + 50 micrograms/ml solution for injection in pre-filled pen
EU/1/16/1157/001-002
Insulin glargine, Lixisenatide Sanofi-Aventis Groupe โ€”
Toujeo (previously Optisulin) 300 units/ml SoloStar solution for injection in a pre-filled pen
EU/1/00/133/033-035
Insulin glargine Sanofi-Aventis Deutschland GmbH โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.